Author

Naomi Wilson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aalim M. WeljieiD· 1 shared Antonijo Mrčela· 1 shared Arjun SenguptaiD· 1 shared Ceylan TanesiD· 1 shared Charles‐Antoine AssenmacheriD· 1 shared Christin HerrmanniD· 1 shared Elliot S. FriedmaniD· 1 shared Emanuela RicciottiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Aalim M. WeljieORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Concomitant suppression of COX-1 and COX-2 is insufficient to induce enteropathy associated with chronic NSAID use

Kayla Barekat, Soumita Ghosh, Christin Herrmann, Karl Keat, Charles‐Antoine Assenmacher, Ceylan Tanes, Naomi Wilson, Ronan Lordan, Antonijo Mrčela, Lubica Rauova, Arjun Sengupta, Ujjalkumar Subhash Das, Robin Joshi, Elliot S. Friedman, Marylyn DeRiggi Ritchie, , Emanuela Ricciotti

The paper shows that suppressing both COX-1 and COX-2 does not cause intestinal injury in mice unless combined with specific NSAIDs, and that gut microbiome changes amplify NSAID-induced enteropathy.

Journal of Clinical Investigation · Jan 27, 2026Peer-reviewedPharmacology & Toxicology